{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:12:59Z","timestamp":1769429579729,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:04:07Z","timestamp":1558083847000},"page":"771-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Human Immunodeficiency Virus-Associated Lymphoproliferative Disorders"],"prefix":"10.1016","volume":"12","author":[{"given":"Amy J.","family":"Lilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.path.2019.03.005_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.path.2019.03.005_bib2","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.path.2019.03.005_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.path.2019.03.005_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/arpa.2012-0095-RA","article-title":"Lymphoid proliferations associated with human immunodeficiency virus infection","volume":"137","author":"Chadburn","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2019.03.005_bib5","first-page":"618760","article-title":"Lymphoproliferative lesions in the setting of HIV infection: a five-year retrospective case series and review","volume":"2011","author":"Mahe","year":"2011","journal-title":"Patholog Res Int"},{"issue":"5","key":"10.1016\/j.path.2019.03.005_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0000000000000986","article-title":"Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy","volume":"30","author":"Olszewski","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.path.2019.03.005_bib7","unstructured":"Swerdlow SH, International Agency for Research on Cancer. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Lyon (France): International Agency for Research on Cancer (IARC) press; 2017."},{"issue":"20","key":"10.1016\/j.path.2019.03.005_bib8","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1182\/blood-2014-11-599951","article-title":"The tumor virus landscape of AIDS-related lymphomas","volume":"125","author":"Arvey","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.005_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2015.06.002","article-title":"Microenvironment and HIV-related lymphomagenesis","volume":"34","author":"Pantanowitz","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.1016\/j.path.2019.03.005_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2217\/bmm.15.13","article-title":"The role of the tumor microenvironment in HIV-associated lymphomas","volume":"9","author":"Taylor","year":"2015","journal-title":"Biomark Med"},{"issue":"30","key":"10.1016\/j.path.2019.03.005_bib11","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1200\/JCO.2008.20.5450","article-title":"Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034","volume":"27","author":"Chadburn","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.path.2019.03.005_bib12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/QAD.0000000000001652","article-title":"Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era","volume":"31","author":"Besson","year":"2017","journal-title":"AIDS"},{"issue":"6769","key":"10.1016\/j.path.2019.03.005_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.path.2019.03.005_bib14","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.path.2019.03.005_bib15","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A\u00a0gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.path.2019.03.005_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.005_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Meyer","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.path.2019.03.005_bib18","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A\u00a0new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.path.2019.03.005_bib19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Muris","year":"2006","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.005_bib20","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V83.6.1460.1460","article-title":"Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2019.03.005_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jcp.56.3.188","article-title":"Burkitt's lymphoma: new insights into molecular pathogenesis","volume":"56","author":"Bellan","year":"2003","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.005_bib22","first-page":"e2009032","article-title":"EBV and HIV-related lymphoma","volume":"1","author":"Bibas","year":"2009","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"10.1016\/j.path.2019.03.005_bib23","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/leu.2017.106","article-title":"HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells","volume":"31","author":"Germini","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.path.2019.03.005_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1309\/PNVQ0PQGXHVY6L7G","article-title":"HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases","volume":"121","author":"Thompson","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.005_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/ijc.30473","article-title":"The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis","volume":"140","author":"Carbone","year":"2017","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.path.2019.03.005_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.03.005_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.semdp.2012.08.006","article-title":"Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV\/HHV8)","volume":"30","author":"Chadburn","year":"2013","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.005_bib28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.path.2019.03.005_bib29","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2019.03.005_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.03.005_bib31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","article-title":"Plasmablastic lymphoma: a review of clinicopathologic features and differential diagnosis","volume":"140","author":"Harmon","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.path.2019.03.005_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jclinpath-2016-204294","article-title":"Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma","volume":"70","author":"Ahn","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"issue":"22","key":"10.1016\/j.path.2019.03.005_bib33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V128.22.1864.1864","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive versus HIV-negative patients: single-center experience","volume":"128","author":"Vasquez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.005_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-015-0163-z","article-title":"Stage,\u00a0age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients","volume":"8","author":"Loghavi","year":"2015","journal-title":"J\u00a0Hematol Oncol"},{"issue":"8","key":"10.1016\/j.path.2019.03.005_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.5858\/arpa.2012-0294-RS","article-title":"Primary effusion lymphoma","volume":"137","author":"Patel","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"18","key":"10.1016\/j.path.2019.03.005_bib36","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood-2018-03-791426","article-title":"Biology and management of primary effusion lymphoma","volume":"132","author":"Shimada","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.005_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.anndiagpath.2012.03.004","article-title":"Extracavitary\/solid variant of primary effusion lymphoma","volume":"16","author":"Kim","year":"2012","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.005_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.005_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/PAS.0b013e318267fabc","article-title":"KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states","volume":"37","author":"Alexanian","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.005_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5582\/irdr.2014.01010","article-title":"Current status of treatment for primary effusion lymphoma","volume":"3","author":"Okada","year":"2014","journal-title":"Intractable rare Dis Res"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:45Z","timestamp":1761748785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300224"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Immunodeficiency Virus-Associated Lymphoproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}